Trial Profile
Clinical Trials Insight: 700023645
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 07 Jun 2007
Price :
$35
*
At a glance
- Drugs Peginterferon alfa-2b (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 07 Jun 2007 New trial record.